Tools
Tools
Vasistha, Navneet A., Johnstone, Mandy, Barton, Samantha K., Mayerl, Steffen E., Thangaraj Selvaraj, Bhuvaneish, Thomson, Pippa A., Dando, Owen, Grünewald, Ellen, Alloza, Clara, Bastin, Mark E., Livesey, Matthew R., Economides, Kyriakos, Magnani, Dario, Makedonopolou, Paraskevi, Burr, Karen, Story, David J., Blackwood, Douglas H. R., Wyllie, David J. A., McIntosh, Andrew M., Millar, J. Kirsty, ffrench-Constant, Charles 
ORCID: https://orcid.org/0000-0002-5621-3377, Hardingham, Giles E., Lawrie, Stephen M. and Chandran, Siddharthan
(2019)
Familial t(1;11) translocation is associated with disruption of white matter structural integrity and oligodendrocyte–myelin dysfunction.
Molecular Psychiatry, 24 (11).
pp. 1641-1654.
ISSN 1359-4184
Abstract
Although the underlying neurobiology of major mental illness (MMI) remains unknown, emerging evidence implicates a role for oligodendrocyte–myelin abnormalities. Here, we took advantage of a large family carrying a balanced t(1;11) translocation, which substantially increases risk of MMI, to undertake both diffusion tensor imaging and cellular studies to evaluate the consequences of the t(1;11) translocation on white matter structural integrity and oligodendrocyte–myelin biology. This translocation disrupts among others the DISC1 gene which plays a crucial role in brain development. We show that translocation-carrying patients display significant disruption of white matter integrity compared with familial controls. At a cellular level, we observe dysregulation of key pathways controlling oligodendrocyte development and morphogenesis in induced pluripotent stem cell (iPSC) derived case oligodendrocytes. This is associated with reduced proliferation and a stunted morphology in vitro. Further, myelin internodes in a humanized mouse model that recapitulates the human translocation as well as after transplantation of t(1;11) oligodendrocyte progenitors were significantly reduced when compared with controls. Thus we provide evidence that the t(1;11) translocation has biological effects at both the systems and cellular level that together suggest oligodendrocyte–myelin dysfunction.
| Item Type: | Article |
|---|---|
| Additional Information: | Funding Information: This work was supported by a Medical Research Council grant to SC, JKM, and AMM, an EU 7th Framework Programme Grant (607616FP7) to JKM and generous funding from the MS Society to SC. NAV was supported by a Department of Biotechnology, Government of India fellowship. MJ is supported by a Wellcome Trust Clinical Career Development Fellowship and The Sackler Foundation. MRL is supported by Royal Society of Edinburgh/Caledonian Research Fund Personal Research Fellowship. The imaging work was originally supported by an award from the Translational Medicine Research Collaboration—a consortium made up of the Universities of Aberdeen, Dundee, Edinburgh, and Glasgow, the four associated NHS Health Boards (Grampian, Tayside, Lothian, and Greater Glasgow and Clyde), Scottish Enterprise, and Pfizer. |
| Uncontrolled Keywords: | molecular biology,psychiatry and mental health,cellular and molecular neuroscience,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/1300/1312 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 15 Jul 2022 14:30 |
| Last Modified: | 25 Sep 2024 16:29 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/86226 |
| DOI: | 10.1038/s41380-019-0505-2 |
Actions (login required)
 |
View Item |